Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
American Heart Journal
|
November 30, 1999
Development of eptifibatide
R M Scarborough
Current Medicinal Chemistry
|
October 16, 1999
Structure-activity relationships of beta-amino acid-containing integrin antagonists
R M Scarborough
Journal of Enzyme Inhibition
|
October 16, 1999
Coagulation factor Xa: the prothrombinase complex as an emerging therapeutic target for small molecule inhibitors
R M Scarborough
Journal of the American Chemical Society
|
October 12, 1977
A stereospecific total synthesis of (+/-)-methylenomycin A. A novel antibiotic possessing an alpha-methylene ketone functionality
R M Scarborough, A B Smith
The American Journal of Cardiology
|
August 18, 1997
Clinical pharmacology of eptifibatide
D R Phillips, R M Scarborough
Journal of Medicinal Chemistry
|
September 23, 2000
Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents
R M Scarborough, D D Gretler
Archives of Pathology & Laboratory Medicine
|
September 18, 1998
Glycoprotein IIb-IIIa in platelet aggregation: an emerging target for the prevention of acute coronary thrombotic occlusions
D R Phillips, D Law, R M Scarborough
Cell
|
May 3, 1991
GPIIb-IIIa: the responsive integrin
D R Phillips, I F Charo, R M Scarborough
Journal of Receptor Research
|
January 1, 1991
Discrimination and quantification of glomerular receptor subtypes for atrial natriuretic factor (ANF)
M C Kollenda, R M Scarborough, A L Gerbes
Circulation
|
July 27, 1999
Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use?
R M Scarborough, N S Kleiman, D R Phillips
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
American Heart Journal
|
November 30, 1999
Development of eptifibatide
R M Scarborough
Current Medicinal Chemistry
|
October 16, 1999
Structure-activity relationships of beta-amino acid-containing integrin antagonists
R M Scarborough
Journal of Enzyme Inhibition
|
October 16, 1999
Coagulation factor Xa: the prothrombinase complex as an emerging therapeutic target for small molecule inhibitors
R M Scarborough
Journal of the American Chemical Society
|
October 12, 1977
A stereospecific total synthesis of (+/-)-methylenomycin A. A novel antibiotic possessing an alpha-methylene ketone functionality
R M Scarborough, A B Smith
The American Journal of Cardiology
|
August 18, 1997
Clinical pharmacology of eptifibatide
D R Phillips, R M Scarborough
Journal of Medicinal Chemistry
|
September 23, 2000
Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents
R M Scarborough, D D Gretler
Archives of Pathology & Laboratory Medicine
|
September 18, 1998
Glycoprotein IIb-IIIa in platelet aggregation: an emerging target for the prevention of acute coronary thrombotic occlusions
D R Phillips, D Law, R M Scarborough
Cell
|
May 3, 1991
GPIIb-IIIa: the responsive integrin
D R Phillips, I F Charo, R M Scarborough
Journal of Receptor Research
|
January 1, 1991
Discrimination and quantification of glomerular receptor subtypes for atrial natriuretic factor (ANF)
M C Kollenda, R M Scarborough, A L Gerbes
Circulation
|
July 27, 1999
Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use?
R M Scarborough, N S Kleiman, D R Phillips
Page
of 6